Paul-Peter Tak
CEO & Board Director

Paul Peter Tak

Paul Peter Tak is a business leader, academic, entrepreneur and clinician who has over 30 years’ experience in medicine as a prominent expert in Immunology, Internal Medicine, and Rheumatology. Paul Peter is currently the President, CEO, and Board Director of Candel Therapeutics, the Co-Founder and Board Director of Sitryx Therapeutics, and Board Director of Levicept and Citryll.

Alongside his industry career, Paul Peter has dedicated much of his life to academia and advancing our understanding in medicine. He has served as Professor of Medicine at the University of Amsterdam and holds numerous honours for his service to medicine, with a special focus on Immunology and Rheumatology.

Candel Therapeutics🔬 $CADL #enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Learn how @CandelTx is leveraging #AI to develop tailored viral immunotherapies that enhance the effectiveness of existing treatments

👉https://candeltx.com

#ad

Load More
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.